noscapine


Also found in: Dictionary, Medical, Wikipedia.

noscapine

[′näs·kə‚pēn]
(pharmacology)
C22H23NO7 A white, colorless, tasteless alkaloid obtained from opium; used as a nonaddicting antitussive.Formerly known as narcotine.
Mentioned in ?
References in periodicals archive ?
They concluded that noscapine administered as a preventive measure may offer significant benefits in the management of prostate cancer.
Their findings said: "Pre-treatment with noscapine confers a significant benefit compared with control in both primary tumor growth and primary tumor growth- inhibition rate and exhibits an extremely favorable tolerability profile.
Cough medicine ingredient noscapine may help fight prostate cancer
Noscapine is a naturally-occurring substance, a non-addictive derivative of opium.
Since noscapine is approved for use in many countries as a cough suppressant, however, it is available to doctors to prescribe for other uses as well.
Cough medicine ingredient could prove effective in prostate cancer treatment
When the investigators gave noscapine to mice with solid tumors, including animals implanted with human breast or bladder tumors, the drug dramatically shrank the cancers.
Noscapine may be a particularly attractive cancer drug, says Ye, because it can be taken orally and has a proven safety record.
Stopping coughs ... and cancer?
14, 2014 /PRNewswire-iReach/ -- The 'Global and Chinese Noscapine Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Noscapine industry with a focus on the Chinese market.
Through the statistical analysis, the report depicts the global and Chinese total market of Noscapine industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
Noscapine Industry (CAS 128-62-1) Global and Chinese Analysis for 2009-2019
Noscapine was originally proposed as an anti-cancer agent in the early 1960's.
New Study Shows Cough Medicine Effective Against Prostate Cancer
As noscapine may represent a new, well-tolerated, oral therapy for the treatment of lymphoma and myeloma, further clinical studies with the drug are warranted.
Cougar Biotechnology Announces Presentation of Positive Preclinical Data for CB3304 (Noscapine) in Non-Hodgkin's Lymphoma and Multiple Myeloma
A larger study of noscapine is warranted to evaluate the efficacy of the compound in patients with lymphoma.
Cougar Biotechnology Announces Positive Interim Results from Phase I trial for CB3304 (Noscapine) in non-Hodgkin's Lymphoma
a privately held biotechnology company, today announced that it has licensed the worldwide, exclusive rights to Emory's intellectual property portfolio for noscapine and analogs of noscapine.
Cougar Biotechnology Licenses Rights to Emory University's Noscapine Patent Portfolio

Encyclopedia browser ?
Full browser ?